Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research
The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Cancer is caused by complex interactions between genes, environment and lifestyles. Biobanks of well-annotated human tissues are an important resource for studying the underlying mechanisms of cancer. Although such biobanks exist, their integration to form larger biobanks is now required to provide the diversity of samples that are needed to study the complexity and heterogeneity of cancer. Clear guidelines and policies are also required to address the challenges of integrating individual institutional or national biobanks and build public trust. This Science and Society article highlights some of the main practical and ethical issues that are undergoing discussion in the integration of tissue biobanks for cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Misinterpretation is a concern when data are assessed without assistance, e.g. from a trained clinician, carer or data scientist (Watson et al. 2010).”
From Ethics of the health-related internet of things: a narrative review (2017) · cites this paper as Watson et al. 2010
Citations
Cites
Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
Cohen, M. H., Williams, G., Johnson, J. R., Duan, J. Z., Gobburu, J. V. S., Rahman, A., Benson, K. A., Leighton, J. K., Kim, S. K., Wood, R., et al. (2002) · PubMed · Cited by 462
Siena, S., Sartore-Bianchi, A., Di Nicolantonio, F., Balfour, J., & Bardelli, A. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp280 · Cited by 429 · cited 1×
“, the use of monoclonal antibodies that target the epidermal growth factor receptor (EGFR) in patients with EGFR-expressing metastatic colon cance”
Should donors be allowed to give broad consent to future biobank research?
Hansson, M. G., Dillner, J., Bartram, C. R., Carlson, J. A., & Helgesson, G. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70618-0 · Cited by 382
Burton, P. R., Hansell, A. L., Fortier, I., Manolio, T. A., Khoury, M. J., Little, J., & Elliott, P. (2009) · International Journal of Epidemiology · doi:10.1093/ije/dyn147 · Cited by 258
Solidarity and equity: new ethical frameworks for genetic databases
Chadwick, R., & Berg, K. (2001) · Nature Reviews Genetics · doi:10.1038/35066094 · Cited by 254
Elger, B. S., & Caplan, A. L. (2006) · EMBO reports · doi:10.1038/sj.embor.7400740 · Cited by 196
Biomarker-Driven Early Clinical Trials in Oncology: A Paradigm Shift in Drug Development
Tan, D. S. W., Thomas, G. V., Garrett, M. D., Banerji, U., de Bono, J. S., Kaye, S. B., & Workman, P. (2009) · The Cancer Journal · doi:10.1097/ppo.0b013e3181bd0445 · Cited by 171
End points in cancer clinical trials and the drug approval process.
Schilsky, R. L. (2002) · PubMed · Cited by 170
A Perspective on Challenges and Issues in Biomarker Development and Drug and Biomarker Codevelopment
Taube, S. E., Clark, G. M., Dancey, J. E., McShane, L. M., Sigman, C. C., & Gutman, S. I. (2009) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djp334 · Cited by 158
Rules for Research on Human Genetic Variation — Lessons from Iceland
Annas, G. J. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422412 · Cited by 115 · cited 1×
“To what extent can such consent about the unknown future be accurately described as informed consent”
Cited by
The ethics of big data: current and foreseeable issues in biomedical contexts
Mittelstadt, B. D., & Floridi, L. (2016) · Science and Engineering Ethics · doi:10.1007/s11948-015-9652-2 · Cited by 714
“For instance, providing data subjects with unrestricted access to raw data may be harmful in the sense that it is practically useless or open to misinterpretation without the presence of a trained clinician or analyst to explain its significance (Watson et al. 2010).”
BackgroundCancer biomarker discovery and validation.
Goossens, N., Nakagawa, S., Sun, X., & Hoshida, Y. (2015) · PubMed · doi:10.3978/j.issn.2218-676x.2015.06.04 · Cited by 503
“However, in part due to the complex and heterogeneous nature of cancer, it has become increasingly recognized, that there is a need for larger integrated biobanks (32,33) which require careful development and adherence to published biobanking guidelines (34).”
BackgroundBiobanking: the foundation of personalized medicine
Hewitt, R. E. (2011) · Current Opinion in Oncology · doi:10.1097/cco.0b013e32834161b8 · Cited by 288
Ethics of the health-related internet of things: a narrative review
Mittelstadt, B. (2017) · Ethics and Information Technology · doi:10.1007/s10676-017-9426-4 · Cited by 154
The Ethics of Big Data: Current and Foreseeable Issues in Biomedical Contexts
Mittelstadt, B. D., & Floridi, L. (2016) · Law, Governance and Technology Series · doi:10.1007/978-3-319-33525-4_19 · Cited by 159
Metadata
- Authors
- Watson, R. W. G., Kay, E. W., & Smith, D.
- Affiliations
- University College Dublin (IE)
- Royal College of Surgeons in Ireland (IE)
- Corresponding author
- Watson, R. William G.
- Venue
- Nature Reviews Cancer
- Published
- 2010-08-12
- Volume
- 10
- Issue
- 9
- Pages
- 646-651
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2030361273
- Cited by
- 88
- References
- 32
- Citations by year
- 2026: 2 · 2024: 1 · 2023: 4 · 2022: 5 · 2021: 15 · 2020: 4 · 2019: 3 · 2018: 9 · 2017: 6 · 2016: 6 · 2015: 5 · 2014: 4 · 2013: 4 · 2012: 11
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- DigitalGeorgetown (Georgetown University Library) (submittedVersion)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Ethics in Clinical Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Health Sciences › Nursing › Issues, ethics and legal aspects › Biomedical Ethics and Regulation
- Keywords
- cancer research, research ethics, public trust, biobank governance, sample diversity, tumor heterogeneity
- MeSH terms
- Animals, Humans, Neoplasms, Guidelines as Topic, Biological Specimen Banks, Bioethical Issues, Ethics, Research
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research. https://app.cochat.ai/papers/10.1038/nrc2913
- The paper
- Watson, R. W. G., Kay, E. W., & Smith, D. (2010). Integrating biobanks: addressing the practical and ethical issues to deliver a valuable tool for cancer research. Nature Reviews Cancer. https://doi.org/10.1038/nrc2913
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.